FEATURED/ARCHIVES (04/05/24)
×
Cost-Effectiveness of Aripiprazole Tablets with Sensor versus Oral Atypical Antipsychotics for the Treatment of Schizophrenia Using a Patient-Level Microsimulation Modeling Approach · May 2023
Articles
ClinicoEconomics and Outcomes Research
×
Cost-Utility Analysis of Repetitive Transcranial Magnetic Stimulation as Add-On Therapy to Standard Care for the Treatment of Hallucinations in Schizophrenia · March 2022
Articles
European Psychiatry
×
Cost-Effectiveness of Aripiprazole Orally Disintegrating Tablets in the Treatment of Schizophrenia in China · September 2020
Abstracts
Expert Review of Pharmacoeconomics and Outcomes Research
×
Cost and Quality-of-Life Impacts of Community Treatment Orders (CTOs) for Patients with Psychosis: Economic Evaluation of the OCTET Trial · July 2020
Articles
Social Psychiatry and Psychiatric Epidemiology
×
Cost Effectiveness of Pharmacogenetic-Guided Clozapine Administration Based on Risk of HLA Variants in Japan and the UK · July 2021
Articles
Translational Psychiatry
×
Healthcare Resource Utilization and Costs among Patients with Schizophrenia Switching from Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis · April 2020
Articles
Current Therapeutic Research
×
Cost-Effectiveness of Early Intervention in Psychosis: A Modeling Study · February 2022
Articles
Psychiatric Services
×
Cost-Effectiveness Analysis of Physical Activity Interventions for People with Schizophrenia or Bipolar Disorder: Systematic Review · August 2023
Articles
British Journal of Psychiatry
×
Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-Based Mirror-Image Study in South Korea · May 2020
Articles
Clinical Psychopharmacology and Neuroscience
×
Real-World Clinical and Cost-Effectiveness of Community Clozapine Initiation: Mirror Cohort Study · April 2022
Articles
British Journal of Psychiatry